Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Current Size And Growth Outlook For The Viral Gastroenteritis Market?
In recent times, the market size for viral gastroenteritis has experienced stable expansion. It is anticipated to grow from a value of $6.75 billion in 2024 to $7.06 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 4.7%. The previous period’s growth could be credited to factors such as the increasing incidents of viral infections, worldwide hygiene habits, progress in diagnostic technology, global travel and tourism, as well as climate and environmental factors.
Over the coming years, significant growth is anticipated in the viral gastroenteritis market, expected to reach a value of $8.69 billion in 2029 with a compound annual growth rate (CAGR) of 5.3%. This escalation in the forecast period can be associated with factors such as worldwide health readiness, implications of climate change, unified health approaches, epidemiological monitoring systems, education, and public consciousness. The upcoming trends within this period encompass progress in vaccine development, sophisticated diagnostic methods, the use of telemedicine for diagnosing, cooperative research ventures, tailored medical treatment strategies, and digital health provisions.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12127&type=smp
What Growth-Enabling Forces Are Impacting The Viral Gastroenteritis Market?
The rise in gastrointestinal disorders is anticipated to boost the viral gastroenteritis market’s growth. This refers to illnesses that occur within or on any part of the gastrointestinal tract. Accordingly, medications and diagnostic treatments for viral gastroenteritis provide suitable therapy for the afflicted. For example, the Impact of IBD Report 2023 published by IBD Clinical and Research Centre—a Canada-based organization dedicated to enhancing the quality of life of patients with Crohn’s disease and ulcerative colitis—reported in September 2023 that, with a prevalence of 825 per 100,000 that year, over 320,000 Canadians have inflammatory bowel disease (IBD). Furthermore, the prevalence is projected to grow by 2.44% annually, implying that approximately 1.1% of the population or 470,000 Canadians will have IBD by 2035. Hence, the rising prevalence of gastrointestinal disorders is stimulating the growth of the viral gastroenteritis market.
How Does The Viral Gastroenteritis Market Differ By Segment?
The viral gastroenteritismarket covered in this report is segmented –
1) By Drugs: Antibiotics; Antacids; Laxatives; Antimotility Agents; Others Drugs
2) By Diagnosis: Physical Examination; Rapid Stool Test
3) By Indication: Watery Diarrhea; Abdominal Cramps; Pain; Other Indications
4) By Type Of Virus: Norovirus; Rotavirus; Astrovirus; Enteric Adenovirus
5) By End User: Hospitals; Clinics; Pharmaceutical Companies; Diagnostic Centers; Ambulatory Care Centers; Others End Users
Subsegments:
1) By Antibiotics: Broad-Spectrum Antibiotics; Narrow-Spectrum Antibiotics; Penicillins; Macrolides; Cephalosporins
2) By Antacids: Proton Pump Inhibitors (PPIs); Histamine-2 Receptor Antagonists (H2 Blockers); Magnesium-Based Antacids; Calcium-Based Antacids; Sodium Bicarbonate
3) By Laxatives: Bulk-Forming Laxatives; Osmotic Laxatives; Stimulant Laxatives; Stool Softeners
4) By Antimotility Agents: Loperamide; Diphenoxylate
5) By Other Drugs: Oral Rehydration Salts (Ors); Zinc Supplements; Antiemetics
What Are The Dominant Trends Currently Seen In The Viral Gastroenteritis Market?
Trend 1 emphasizes the importance of product innovation in the viral gastroenteritis market. To cement their market stance, leading firms are prioritizing the creation of innovative products. In November 2022, an example occurred when GlaxoSmithKline PLC, a biopharmaceutical firm headquartered in the UK, earned approval from the US Food and Drug Administration (FDA) for its ROTARIX oral-dosing applicator-only presentation, a liquid formulation designed to prevent rotavirus gastroenteritis in infants. This new mode of presentation simplifies the role of healthcare providers by rendering it unnecessary to reconstitute the vaccine dose at the time of use. Worldwide clinical trial data, indicating safety and tolerance comparable to the lyophilized formulation as well as immunogenicity’s non-inferiority, supports the approval.
Who Are The Most Influential Companies In The Viral Gastroenteritis Market?
Major companies operating in the viral gastroenteritis market include Pfizer Inc., Abbvie Inc., Sanofi S.A., Abbott Laboratories, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, C.H. Boehringer Sohn AG & Co. KG, Mylan N.V., Astellas Pharma Inc., Fresenius Kabi AG, Bausch Health Companies Inc., Alexion Pharmaceuticals Inc., Horizon Therapeutics Plc, Dr. Reddy’s Laboratories Ltd., BioMarin Pharmaceutical Inc., Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Ltd, Ironwood Pharmaceuticals Inc, ANI Pharmaceuticals Inc., Merck Sharp & Dohme Corp., Allergan plc, Haustus Biotech Private Limited, Gracia Lifesciences India Private Limited
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/viral-gastroenteritis-global-market-report
Which Region Is Leading Innovation In The Viral Gastroenteritis Market?
North America was the largest region in the viral gastroenteritis market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral gastroenteritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12127&type=smp
Browse Through More Reports Similar to the Global Viral Gastroenteritis Market 2025, By The Business Research Company
Forklift Truck Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/forklift-truck-global-market-report
Point Of Sale Terminals Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/point-of-sale-terminals-global-market-report
Warehouse Execution System Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/warehouse-execution-system-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model